Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-03-03
1988-04-26
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514228, 514231, 514234, 514253, 514278, 514369, 514382, 544 70, 544230, 546 15, 548147, 548253, 548309, A61K 31415, C07D491107
Patent
active
047405171
ABSTRACT:
A spiro-3-heteroazolidine compound and agents comprising that compound which have special utility as an antidiabetic composition and as a substance to inhibit aldose reductase enzyme activity.
REFERENCES:
patent: 4540704 (1985-09-01), Ueda et al.
Kinoshita, J., et al., Jap. J. Opthalmol., vol. 20, pp. 399-410 (1976).
Gabbay, K., Int. Congr. Ser. Excerpta. Med., vol. 403, pp. 594-598 (1977).
Peterson, M., et al., Metabolism, vol. 28, pp. 456-461 (1979).
CA, vol. 69, 2798q (1968) [Canalini, G., et al., Ann. Chim. 1967, 57(10), 1045-72].
CA, vol. 70, 47334x (1969) [Fravolini, A., et al., Ann. Chim. 1968, 58(10), 1155-62].
Kabbe, M. Synthesis, pp. 886-887 (1978).
Fukushima Masato
Kurono Masayasu
Matsubara Akira
Mizuno Kuniharu
Usui Toshinao
Sanwa Kagaku Kenyusho Co., Ltd.
Schwartz Richard A.
LandOfFree
Antidiabetic spiro-3-heteroazolidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidiabetic spiro-3-heteroazolidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidiabetic spiro-3-heteroazolidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-819838